Tesamorelin 10mg (10 Vials)

Overview

Tesamorelin is a laboratory research material used to examine receptor-mediated signaling, pituitary responsiveness, and hormone-pathway behavior in controlled experimental models. References to published clinical or disease-context literature are provided only to explain the background of the compound and must not be interpreted as claims of therapeutic, diagnostic, or clinical benefit for this product. This product is not offered for human or veterinary use.

Tesamorelin : Structure

Sequence (Single Letter): Unk-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu

Molecular Formula: C₂₂₃H₃₇₀N₇₂O₆₈S

Molecular Weight: 5195.908 g/mol

PubChem CID: 44147413

CAS Number: 901758-09-6

Source:

PubChem

Research Characteristics of Tesamorelin

Tesamorelin is used in laboratory studies to examine GHRH-receptor signaling, GH pulsatility, IGF-1 responses, and visceral adipose tissue models under controlled experimental conditions. Any references to metabolic, muscle-related, inflammatory, or tissue-related pathways are included only to describe research context and do not imply therapeutic or clinical use.

Laboratory Handling and Research Compliance

Tesamorelin 10mg supplied for research purposes is intended strictly for in vitro or approved investigational use. It is not approved for ingestion, injection, or administration to humans or animals outside of sanctioned research protocols. Proper storage, handling, and documentation should be maintained in accordance with institutional and regulatory guidelines.

Why Choose Licensed Peptides for Tesamorelin 10mg?

At Licensed Peptides, we’re committed to offering premium research-grade Tesamorelin 10mg at some of the most competitive prices in the industry, without ever cutting corners on quality or service. Proudly based in the United States, we ensure every order is handled with precision, from trusted sourcing to secure fulfillment. Each vial is expertly packaged to maintain stability, protect integrity, and arrive in perfect condition.

Shopping with us is effortless. Our streamlined online checkout is fast, safe, and supports all major credit and debit cards for a smooth, hassle-free buying experience. Once your payment is successfully processed, we move quickly, your Tesamorelin ships promptly and discreetly, so you get exactly what you need, exactly when you need it.

Frequently Asked Questions (Research-Only)

What is Tesamorelin?

Tesamorelin is a synthetic GHRH analogue used in laboratory research to study endogenous growth hormone regulation, IGF-1 signaling, and visceral adipose tissue models. It is not approved for general use.

How does Tesamorelin function mechanistically?

It binds to GHRH receptors in the anterior pituitary, stimulating natural GH release through established endocrine pathways rather than introducing external hormones.

Why is Tesamorelin often studied for visceral fat?

Researchers use Tesamorelin in visceral adipose tissue models because it interacts with GH/IGF-1 signaling and related metabolic pathways in controlled experimental systems.

Is Tesamorelin the same as growth hormone?

No. Tesamorelin stimulates endogenous GH production, whereas growth hormone introduces an external hormone. This distinction is central to many research designs.

How long do studies typically observe changes?

Study timelines vary by protocol and model. Any timing references in the literature are provided for research context only and are not product performance claims.

Does Tesamorelin directly build muscle in studies?

Tesamorelin is not considered anabolic. Any muscle-related findings discussed in the literature are reported within research contexts only and do not constitute claims of human or animal benefit.

Are effects maintained after research exposure ends?

Published studies may examine whether certain experimental outcomes persist or change after exposure ends. This is research context only and does not imply therapeutic benefit.

What is known about safety in research environments?

Published research may report tolerability observations under defined study conditions. These observations are included for scientific context only and do not indicate approval for human or veterinary use.

Does Tesamorelin affect insulin signaling in studies?

Some research models examine insulin-related markers in relation to GH/IGF-1 and visceral adipose tissue pathways. This is research context only and does not imply clinical benefit.

How long is Tesamorelin active biologically?

Tesamorelin is studied for its receptor-mediated signaling profile and downstream endocrine response behavior. Timing observations are model-dependent and are included only for research context.

What differentiates Tesamorelin from other peptides?

Tesamorelin is studied as a GHRH analogue with specific relevance to GH/IGF-1 signaling and visceral adipose tissue research models. This is descriptive research context only.

What does LPS-free peptide mean in relation to Tesamorelin 10 mg?

An LPS-free peptide indicates that the material has been tested to ensure the absence of lipopolysaccharides, which are bacterial endotoxins that could interfere with experimental outcomes in sensitive research assays.

Why is Tesamorelin described as an endotoxin-free peptide?

Being an endotoxin-free peptide means the product meets strict endotoxin limits, supporting accuracy and reliability in laboratory and investigative research where endotoxin contamination could compromise data integrity.

Tesamorelin: Research

Growth Hormone & HIV

Any references to HIV, lipodystrophy, growth hormone, or IGF-1 in the scientific literature are provided solely to describe published research context. They do not indicate that this product is intended for human treatment, diagnosis, or clinical use.

Lipodystrophy

Published studies on body-composition changes are included here for educational context only. They do not constitute claims of therapeutic benefit or approved use.

Peripheral nerve damage

Any discussion of nerve-injury models is included only to summarize research context and does not imply therapeutic or clinical use of this product.

Referenced Citations

Rochira V, Guaraldi G. Growth hormone deficiency and human immunodeficiency virus. Best Pract Res Clin Endocrinol Metab. 2017 Feb;31(1):91-111. doi: 10.1016/j.beem.2017.02.006. Epub 2017 Feb 24. PMID: 28477736.

Dhillon S. Tesamorelin: a review of its use in the management of HIV-associated lipodystrophy. Drugs. 2011 May 28;71(8):1071-91. doi: 10.2165/11202240-000000000-00000. PMID: 21668043.

Tuffaha SH, Singh P, Budihardjo JD, Means KR, Higgins JP, Shores JT, Salvatori R, Höke A, Lee WP, Brandacher G. Therapeutic augmentation of the growth hormone axis to improve outcomes following peripheral nerve injury. Expert Opin Ther Targets. 2016 Oct;20(10):1259-65. doi: 10.1080/14728222.2016.1188079. Epub 2016 May 24. PMID: 27192539.

ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY.

The products available on this website are intended solely for in-vitro research purposes (Latin: “in glass”), meaning they are used in experiments conducted outside a living organism. These products are not medicines or drugs, have not been evaluated or approved by the U.S. Food and Drug Administration (FDA), and are not intended to diagnose, treat, cure, or prevent any disease or medical condition. Any administration to humans or animals, whether by ingestion, injection, or other means, is strictly prohibited by law.